missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Voriconazole Pharmaceutical Secondary Standard:, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR18921G
Description
Voriconazole is a synthetically prepared, broad-spectrum triazole derivative of fluconazole, which shows in vitro activity against many yeasts and a broad-spectrum of mold and dermatophyte isolates. Its mode of action involves the inhibition of cytochrome P450 (CYP)-dependent enzyme, 14-α-sterol demethylase, and hence it is involved in disrupting the cell membrane and terminate the fungal growth.Specifications
| 137234-62-9 | |
| C16H14F3N5 O | |
| Voriconazole; 2 R,3 S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1 H-1,2,4-triazol-1-yl)butan-2-ol; UK-109496 | |
| 1 g | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00905717 | |
| Certified Reference Material | |
| 349.31 |